Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCC Cyclacel Pharmaceuticals

交易中 05-30 12:16:41 EDT

2.04

-0.01

-0.49%

最高2.05	最低2.01	成交量1.03万
今开2.04	昨收2.05	日振幅1.82%
总市值298.50万	流通市值262.45万	总股本146.33万
成交额2.10万	换手率0.80%	流通股本128.65万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCC","market":"US","secType":"STK","nameCN":"Cyclacel Pharmaceuticals","latestPrice":2.04,"timestamp":1717085054022,"preClose":2.05,"halted":0,"volume":10323,"delay":0,"floatShares":1286500,"shares":1463259,"eps":-20.542479,"marketStatus":"交易中","marketStatusCode":2,"change":-0.01,"latestTime":"05-30 12:16:41 EDT","open":2.04,"high":2.0473,"low":2.01,"amount":21000.1047075,"amplitude":0.018195,"askPrice":2.05,"askSize":147,"bidPrice":1.99,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-20.542479,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1717099200000},"adr":0,"listingDate":1079413200000,"adjPreClose":2.05,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.02,"preClose":2.05,"latestTime":"08:12 EDT","volume":30,"amount":60.6,"timestamp":1717071149781},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.05,"latestTime":"19:54 EDT","volume":182,"amount":367.93,"timestamp":1717026845793},"volumeRatio":0.524751},"requestUrl":"/m/hq/s/CYCC/wiki","defaultTab":"wiki","newsList":[{"id":"2439831195","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.85%报1.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439831195","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439831195?lang=zh_cn&edition=full","pubTime":"2024-05-29 01:25","pubTimestamp":1716917137,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日01时25分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.85%。截至发稿，该股报1.93美元/股，成交量2.0831万股，换手率1.42%，振幅9.76%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.85%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529012538941eaac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529012538941eaac6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437248773","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437248773","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2437248773?lang=zh_cn&edition=full","pubTime":"2024-05-23 03:55","pubTimestamp":1716407706,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日03时55分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.22%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃，换手率分别为360.60%、178.61%、59.88%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Alpha Tau Medical Ltd C/Wts ，振幅分别为61.52%、57.14%、48.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523035506861ee637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523035506861ee637&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2436193396","title":"Cyclacel Pharmaceuticals, Inc.2024财年第一财季实现净利润-2.95百万美元，同比增加49.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436193396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436193396?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:08","pubTimestamp":1716134916,"startTime":"0","endTime":"0","summary":"3月31日，Cyclacel Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-2.95百万美元，同比增加49.14%；其中营业收入为29000.00美元，每股基本收益为-2.27美元。从资产负债表来看，Cyclacel Pharmaceuticals, Inc.总负债8.37百万美元，其中短期债务0.00美元，资产负债比为0.74，流动比率为0.58。机构评级：截至2024年3月31日，当前有2家机构对Cyclacel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为11.00美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000844877ab257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000844877ab257&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435525071","title":"Cyclacel 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435525071","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435525071?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:01","pubTimestamp":1715720518,"startTime":"0","endTime":"0","summary":"   * Cyclacel Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损2.27美元，高于去年同期的每股收益7.05美元。两位分析师对该季度的平均预期是每股亏损 4.74 美元。华尔街预期为每股亏损 4.93 至 4.56 美元。* 公司季度亏损 295 万美元。* Cyclacel Pharmaceuticals Inc 本季度股价上涨了 20.4%，今年迄今为止亏损了 4.9%。华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元。本摘要由 LSEG 5 月 14 日 09:01 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2435651628","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘大幅跳水11.42%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435651628","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435651628?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693478,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速跳水11.42%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为35.02%、7.15%、6.50%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Allogene Therapeutics, Inc.、Taysha Gene Therapies, Inc.，振幅分别为21.54%、12.41%、10.62%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131188768edc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131188768edc0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435037396","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 急速拉升10.57%报2.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435037396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435037396?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:32","pubTimestamp":1715607135,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升10.57%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Nutriband Inc C/Wts 、Ac Immune Sa、Tevogen Bio Holdings Inc.涨幅较大，Allarity Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.、Reneo Pharmaceuticals, Inc.较为活跃，换手率分别为22.68%、15.50%、13.53%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc.、Ac Immune Sa，振幅分别为26.92%、12.19%、10.82%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321321587625f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321321587625f2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434309016","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.60%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434309016","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434309016?lang=zh_cn&edition=full","pubTime":"2024-05-09 22:03","pubTimestamp":1715263399,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日22时03分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.60%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Notable Labs, Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Notable Labs, Ltd.较为活跃，换手率分别为66.56%、19.49%、16.70%，振幅较大的相关个股有Notable Labs, Ltd.、Jasper Therapeutics Inc C/Wts 24/09/2026 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为45.48%、22.78%、21.74%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092203207926c95c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092203207926c95c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433610207","title":"Cyclacel Pharmaceuticals Inc   预计每股亏损4.74美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433610207","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433610207?lang=zh_cn&edition=full","pubTime":"2024-05-08 10:25","pubTimestamp":1715135105,"startTime":"0","endTime":"0","summary":"   * Cyclacel Pharmaceuticals Inc    预计在5月9日公布截至0001年1月1日的业绩时，其季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Cyclacel Pharmaceuticals Inc 每股亏损 4.74 美元。* 华尔街对 Cyclacel Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元，高于其上一次收盘价 2.11 美元。5月8日 - 本摘要于北京时间 5 月 8 日 02:24 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433787182","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨5.31%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433787182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433787182?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:09","pubTimestamp":1715098173,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日00时09分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.31%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Carmell Corp C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1434.78%、219.82%、183.38%，振幅较大的相关个股有Avenue Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进，振幅分别为42.73%、41.69%、41.38%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508000934861eb846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508000934861eb846&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433770754","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速拉升6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433770754","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433770754?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:39","pubTimestamp":1715006357,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时39分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.00%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Tc Biopharm  Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 、Nrx Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1055.90%、696.14%、62.65%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062239187a584a10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062239187a584a10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432906622","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.02%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432906622","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432906622?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:18","pubTimestamp":1714745908,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日22时18分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价快速下挫6.02%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Ardelyx, Inc.、Vaxxinity, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为127.87%、31.63%、23.50%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Effector Therapeutics Inc C/Wts 31/12/2025 、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为59.38%、30.65%、28.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032218297a57fc84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032218297a57fc84&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432604835","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432604835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432604835?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:34","pubTimestamp":1714656845,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时34分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速下挫6.79%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Allarity Therapeutics, Inc.、Context Therapeutics Inc.、Aptevo Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为1727.58%、306.40%、84.59%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为50.36%、22.07%、21.42%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022134058b6d2a3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022134058b6d2a3c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431257393","title":"Cyclacel Pharmaceuticals, Inc.股价拉升39.34% 市值涨98.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431257393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431257393?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:31","pubTimestamp":1714483882,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨39.34%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Hcw Biologics Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为503.87%、160.13%、7.23%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Harmony Biosciences Holdings, Inc.、Nrx Pharmaceuticals, Inc.，振幅分别为10.41%、6.67%、6.48%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021312287c3f53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021312287c3f53b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431865772","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘快速跳水12.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431865772","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431865772?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397464,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价急速跳水12.58%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为390.93%、22.51%、9.65%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Calcimedica, Inc.，振幅分别为19.05%、13.83%、10.09%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发治疗癌症和其他增生性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921310487bf998e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921310487bf998e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285937","title":"Cyclacel Pharmaceuticals, Inc.股价重挫16.52% 市值跌41.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285937","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430285937?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:32","pubTimestamp":1714051964,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时32分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下跌16.52%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为534.88%、181.15%、5.87%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、Lyell Immunopharma, Inc.，振幅分别为18.13%、14.20%、12.14%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252132448b533101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252132448b533101&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113662","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 快速上涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429113662?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:43","pubTimestamp":1713879781,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时43分，Cyclacel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.71%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Biomx Inc.、Tiziana Life Sciences Ltd涨幅较大，Silo Pharma, Inc.、Nkgen Biotech, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为162.93%、23.33%、5.74%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Immunitybio, Inc.、Azitra Inc，振幅分别为18.68%、18.42%、12.41%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321430187a66232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321430187a66232&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429330920","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429330920","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429330920?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:33","pubTimestamp":1713796416,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时33分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.06%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为163.57%、56.04%、44.00%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为198.51%、68.57%、31.66%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422223336861e7db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422223336861e7db8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428751982","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428751982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428751982?lang=zh_cn&edition=full","pubTime":"2024-04-18 23:44","pubTimestamp":1713455073,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日23时44分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅下跌7.14%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为8583.74%、99.23%、37.57%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Aileron Therapeutics, Inc.，振幅分别为86.72%、73.93%、63.53%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418234433792194ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418234433792194ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428617345","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 股价大涨8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428617345","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428617345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:35","pubTimestamp":1713360905,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时35分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨8.38%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.51%、22.73%、19.62%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Jaguar Health, Inc.、Viracta Therapeutics, Inc.，振幅分别为25.30%、16.55%、15.75%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213505861e6b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213505861e6b4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427513881","title":"Cyclacel Pharmaceuticals, Inc.盘中异动 大幅下跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427513881","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427513881?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:17","pubTimestamp":1713201452,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时17分，Cyclacel Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.11%。Cyclacel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1493.02%、1209.80%、839.99%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、114.53%、80.04%。Cyclacel Pharmaceuticals, Inc.公司简介：Cyclacel Pharmaceuticals Inc 是一家临床阶段的生物制药公司，开发针对癌症和其他增殖性疾病的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160117327a52e094&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160117327a52e094&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclacel.com","stockEarnings":[{"period":"1week","weight":-0.0339},{"period":"1month","weight":0.5074},{"period":"3month","weight":-0.1992},{"period":"6month","weight":-0.4936},{"period":"1year","weight":-0.786},{"period":"ytd","weight":-0.2322}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0314},{"period":"3month","weight":0.0355},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.2521},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclacel Pharmaceuticals, Inc.是一家于1996年成立且处于发展阶段的生物制药公司，致力于用于治疗人类癌症和其它重大疾病的新药和与机体有关的药品的开发和商业化。Cyclacel是细胞周期领域的开拓者，它敢于利用仅适合口服的新药来治疗患者。它的目标是在其一系列商业产品和新药筛选机制发展的基础上成为一家着重于血液学、肿瘤学研究的多元化生物医学公司。作为一家处于发展阶段的企业，该公司所有的努力都贡献于其研究和发展上，指导临床试验，开发和收购新的知识产权，提高资金储备和收益率及训练员工。它的目标是开发和商业化面向细胞周期控制各个阶段和用于治疗癌症及其他重大疾病的小分子药物，尤其是那些医疗缺口很大的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.006177},{"month":2,"riseRate":0.444444,"avgChangeRate":0.08133},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.059058},{"month":4,"riseRate":0.421053,"avgChangeRate":-0.01166},{"month":5,"riseRate":0.368421,"avgChangeRate":-0.025907},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.086137},{"month":7,"riseRate":0.5,"avgChangeRate":-0.041555},{"month":8,"riseRate":0.277778,"avgChangeRate":-0.079},{"month":9,"riseRate":0.5,"avgChangeRate":-0.005826},{"month":10,"riseRate":0.333333,"avgChangeRate":0.010843},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.012713},{"month":12,"riseRate":0.5,"avgChangeRate":-0.018954}],"exchange":"NASDAQ","name":"Cyclacel Pharmaceuticals","nameEN":"Cyclacel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclacel Pharmaceuticals,CYCC,Cyclacel Pharmaceuticals股票,Cyclacel Pharmaceuticals股票老虎,Cyclacel Pharmaceuticals股票老虎国际,Cyclacel Pharmaceuticals行情,Cyclacel Pharmaceuticals股票行情,Cyclacel Pharmaceuticals股价,Cyclacel Pharmaceuticals股市,Cyclacel Pharmaceuticals股票价格,Cyclacel Pharmaceuticals股票交易,Cyclacel Pharmaceuticals股票购买,Cyclacel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclacel Pharmaceuticals(CYCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclacel Pharmaceuticals(CYCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}